Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restylane Silk for Chest Wrinkles
NCT03324997Phase 2Withdrawn
- Start
- Jan 2018
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms). Primary endpoints: Change in Fabi-Bolton (FB) clinometric chest wrinkle scale at 6 months and Incidence of reported treatment emergent adverse events at 360 days. Planned start Jan 2018; status: withdrawn.
Beyond the preview
Go deeper on NCT03324997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324997.